AAAAAA
Results:
1-22
|
Results: 22
Authors:
Faergeman, O
Citation: O. Faergeman, A collective failure of medical practice?, EUR HEART J, 22(7), 2001, pp. 526-528
Authors:
Brorholt-Petersen, JU
Jensen, HK
Raungaard, B
Gregersen, N
Faergeman, O
Citation: Ju. Brorholt-petersen et al., LDL-receptor gene mutations and the hypocholesterolemic response to statintherapy, CLIN GENET, 59(6), 2001, pp. 397-405
Authors:
Faergeman, O
Citation: O. Faergeman, The atherosclerosis epidemic: Methodology, nosology, and clinical practice, AM J CARD, 88(2A), 2001, pp. 4E-7E
Authors:
Faergeman, O
Citation: O. Faergeman, The revised joint guidelines, ATHEROSCL S, 1(1), 2000, pp. 3-7
Authors:
Faergeman, O
Citation: O. Faergeman, Hypertriglyceridemia and the fibrate trials, CURR OP LIP, 11(6), 2000, pp. 609-614
Authors:
Jensen, JM
Gerdes, LU
Jensen, HK
Christiansen, TM
Brorholt-Petersen, JU
Faergeman, O
Citation: Jm. Jensen et al., Association of coronary heart disease with age-adjusted aortocoronary calcification in patients with familial hypercholesterolaemia, J INTERN M, 247(4), 2000, pp. 479-484
Authors:
Wood, D
de Backer, G
Faergeman, O
Graham, I
Mancia, G
Pyorala, K
Bokarew, O
Cambien, F
Cifkova, R
Gohlke, H
Gutzwiller, F
Klein, W
Poole-wilson, PA
Priori, S
Citation: D. Wood et al., Prevention of coronary heart disease in clinical practice summary of recommendations, REV ESP CAR, 53(3), 2000, pp. 413-421
Authors:
Raungaard, B
Brorholt-Petersen, JU
Jensen, HK
Faergeman, O
Citation: B. Raungaard et al., Flow cytometric assessment of effects of fluvastatin on low-density lipoprotein receptor activity in stimulated T-lymphocytes from patients with heterozygous familial hypercholesterolemia, J CLIN PHAR, 40(4), 2000, pp. 421-429
Authors:
Raungaard, B
Jensen, HK
Brorholt-Petersen, JU
Heath, F
Faergeman, O
Citation: B. Raungaard et al., Functional characterization of two low density lipoprotein receptor gene mutations by fluorescence flow cytometric assessment of receptor activity instimulated human T-lymphocytes, CLIN GENET, 57(2), 2000, pp. 110-115
Authors:
Raungaard, B
Heath, F
Hansen, PS
Brorholt-Petersen, JU
Jensen, HK
Faergeman, O
Citation: B. Raungaard et al., Flow cytometric assessment of LDL ligand function for detection of heterozygous familial defective apolipoprotein B-100, CLIN CHEM, 46(2), 2000, pp. 224-233
Authors:
Gerdes, LU
Gerdes, C
Kervinen, K
Savolainen, M
Klausen, IC
Hansen, PS
Kesaniemi, YA
Faergeman, O
Citation: Lu. Gerdes et al., The apolipoprotein epsilon 4 allele determines prognosis and the effect onprognosis of simvastatin in survivors of myocardial infarction - A substudy of the Scandinavian Simvastatin Survival Study, CIRCULATION, 101(12), 2000, pp. 1366-1371
Authors:
Pedersen, TR
Wilhelmsen, L
Faergeman, O
Strandberg, TE
Thorgeirsson, G
Troedsson, L
Kristianson, J
Berg, K
Cook, TJ
Haghfelt, T
Kjekshus, J
Miettinen, T
Olsson, AG
Pyorala, K
Wedel, H
Citation: Tr. Pedersen et al., Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering, AM J CARD, 86(3), 2000, pp. 257-262
Authors:
Faergeman, O
Citation: O. Faergeman, Challenges to best practice: why are guidelines not implemented?, EUR H J SUP, 1(J), 1999, pp. J12-J17
Authors:
Faergeman, O
Citation: O. Faergeman, New British recommendations for prevention of coronary heart disease in clinical practice, HEART, 81(4), 1999, pp. 335-335
Authors:
Pedersen, TR
Faergeman, O
Citation: Tr. Pedersen et O. Faergeman, Simvastatin seems unlikely to cause impotence, BR MED J, 318(7177), 1999, pp. 192-192
Authors:
Raungaard, B
Heath, F
Brorholt-Petersen, JU
Jensen, HK
Faergeman, O
Citation: B. Raungaard et al., Flow cytometric assessment of LDL receptor activity peripheral blood mononuclear cells compared to gene mutation detection in diagnosis of heterozygous familial hypercholesterolemia, CYTOMETRY, 36(1), 1999, pp. 52-59
Authors:
Wood, D
de Backer, G
Graham, I
Mancia, G
Pyorala, K
Ryden, L
Faergeman, O
van Zwieten, P
Citation: D. Wood et al., Coronary heart disease prevention task force - Reply, EUR HEART J, 20(11), 1999, pp. 843-844
Authors:
Jensen, HK
Jensen, LG
Meinertz, H
Hansen, PS
Gregersen, N
Faergeman, O
Citation: Hk. Jensen et al., Spectrum of LDL receptor gene mutations in Denmark: implications for molecular diagnostic strategy in heterozygous familial hypercholesterolemia, ATHEROSCLER, 146(2), 1999, pp. 337-344
Authors:
Cenarro, A
Casao, E
Civeira, F
Jensen, HK
Faergeman, O
Pocovi, M
Citation: A. Cenarro et al., Pl(A1/A2) polymorphism of platelet glycoprotein IIIa and risk of acute coronary syndromes in heterozygous familial hypercholesterolemia, ATHEROSCLER, 143(1), 1999, pp. 99-104
Authors:
Jensen, HK
Jensen, LG
Holst, HU
Andreasen, PH
Hansen, PS
Larsen, ML
Kolvraa, S
Bolund, L
Gregersen, N
Faergeman, O
Citation: Hk. Jensen et al., Normolipidemia and hypercholesterolemia in persons heterozygous for the same 1592+5G -> A splice site mutation in the low-density lipoprotein receptor gene, CLIN GENET, 56(5), 1999, pp. 378-388
Authors:
Jensen, JM
Kruse, TA
Brorholt-Petersen, JU
Christiansen, TM
Jensen, HK
Kolvraa, S
Faergeman, O
Citation: Jm. Jensen et al., Linking genotype to aorto-coronary atherosclerosis: a model using familialhypercholesterolemia and aorto-coronary calcification, ANN HUM GEN, 63, 1999, pp. 511-520
Authors:
Wood, D
De Backer, G
Faergeman, O
Graham, I
Mancia, G
Pyorala, K
Citation: D. Wood et al., Prevention of coronary heart disease in clinical practice: Recommendationsof the Second Joint Task Force of European and other Societies on CoronaryPrevention, ATHEROSCLER, 140(2), 1998, pp. 199-270
Risultati:
1-22
|